Robotic gastrectomy versus laparoscopic gastrectomy in patients with gastric cancer: A randomized Phase III trial
Phase 3
- Conditions
- Resectable gastric cancer
- Registration Number
- JPRN-UMIN000031536
- Lead Sponsor
- Second Department of Surgery, Wakayama Medical University, School of Medicine
- Brief Summary
JAMA Surg. 2021 Oct 1;156(10):954-963. doi: 10.1001/jamasurg.2021.3182.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
1) Synchronous or metachronous malignancies other than carcinoma in situ 2) Pregnancy or breast-feeding 3) Severe mental disease 4) Continuous systemic steroid therapy 5) History of myocardial infarction or unstable angina pectoris within six months 6) Uncontrollable hypertension 7) Uncontrollable diabetes mellitus or administration of insulin 8) Respiratory disease requiring continuous oxygen therapy 9) History of deep vein thrombosis 10)Doctors decision not to register to this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of intra-abdominal infectious complications (pancreatic fistula, intra-abdominal abscess, and anastomotic leakage) with more than Clavien-Dindo grade 2
- Secondary Outcome Measures
Name Time Method Incidence of postoperative complications, duration of surgery, blood loss, blood transfusion, time to first oral intake, length of stay, relapse-free survival, overall survival rate